Mirabegron And Ureteral Stent-related Pain (MAP) Trial
Clinical trial NCT04286152 · UNKNOWN
Trial details
- NCT number
- NCT04286152
- Sponsor
- Unity Health Toronto
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-03
- Primary completion
- 2021-02-28
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.